Xarelto — Nutrient Associations & Health Patterns

Also known as: Rivaroxaban (Xarelto)

Drug Class: Direct oral anticoagulant (DOAC) — Factor Xa inhibitor

Xarelto is a Direct oral anticoagulant (DOAC) — Factor Xa inhibitor that may affect nutrient status or medication timing in some contexts. WePattern Pattern Health Intelligence maps evidence-qualified nutrient associations, side effects, and interaction context linked to Xarelto.

Reported Nutrient Associations for Xarelto

Peer-reviewed research reports relationships involving the following nutrients. WePattern surfaces them as evidence-qualified associations; they do not establish deficiency, causation, or a fixed timeline for an individual.

Common Side Effects of Xarelto

Key Drug Interactions — Xarelto

Xarelto has 9 documented drug-drug interactions in WePattern's Pattern Health Intelligence database. Key interactions include:

Frequently Asked Questions

What nutrient associations are reported for Xarelto?

Xarelto has reported nutrient associations involving Vitamin K2, Coenzyme Q10 (CoQ10) in clinical research. This does not establish that every person will become deficient or that the medication caused an individual result.

Which nutrient relationships are mapped for Xarelto?

WePattern maps reported associations involving: Vitamin K2, Coenzyme Q10 (CoQ10). The strength, mechanism, dose, duration, and clinical relevance vary, so a clinician or pharmacist should interpret them in context.

What are the side effects of Xarelto?

Common side effects associated with Xarelto include: Bleeding (the primary risk — internal, GI, or external); Bruising easily; Prolonged bleeding from cuts; GI bleeding (stomach pain, bloody or black stools); Nausea.

Explore Related Health Intelligence